First Trust Advisors’s scPharmaceuticals SCPH Stock Holding History

First Trust Advisors’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-23,614	Closed	-$144K	–	2622
2021 Q2	$144K	Sell	23,614 -823	-3%	-$4.96K	﹤0.01%	2450
2021 Q1	$163K	Buy	24,437 +1,963	+9%	+$13.5K	﹤0.01%	2388
2020 Q4	$119K	Sell	22,474 -1,015	-4%	-$7.95K	﹤0.01%	2288
2020 Q3	$175K	Buy	+23,489	New	+$184K	﹤0.01%	2248

Other funds holding SCPH

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

First Trust Advisors's SCPH Position: Q3 2021 in Review

First Trust Advisors sold out of scPharmaceuticals (SCPH) in Q3 2021, closing a stake of 23,614 shares — an estimated $144K sold.

First Trust Advisors first reported a position in SCPH in Q3 2020 and held it in 4 quarters. The position peaked at $175K in Q3 2020. 31 funds tracked by Wall St. Rank hold SCPH as of Q3 2021.

First Trust Advisors reported no remaining scPharmaceuticals position as of Q3 2021 after selling out during the quarter.
First Trust Advisors sold 23,614 scPharmaceuticals shares in Q3 2021, an estimated $144K.
First Trust Advisors first reported a position in scPharmaceuticals in Q3 2020 and held it in 4 quarters.
First Trust Advisors's scPharmaceuticals position peaked at $175K in Q3 2020.
31 funds tracked by Wall St. Rank held scPharmaceuticals as of Q3 2021.

Based on First Trust Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.